Boston Scientific Corp (BSX)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$47.40
Buy
$47.41
$-0.275 (-0.58%)
Prices updated at 03 Jun 2026, 17:48 EDT
| Prices minimum 15 mins delay
Prices in USD
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Michael F. Mahoney
CEO
Mr. Michael F. Mahoney
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
59,000
Head office
300 Boston Scientific Way
Marlborough
United States
01752-1234
Key personnel
Owner name | Salary |
|---|---|
Mr. Christophe Pierre Weber Director | - |
Ms. Catherine R. Smith Director | - |
Mr. David C. Habiger Independent Director | 0.12m |
Mr. Edward J. Ludwig Lead Independent Director | 0.17m |
Mr. David S. Wichmann Independent Director | 0.15m |
Ms. Ellen M. Zane Independent Director | 0.15m |
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiovascular | 0.89m |
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer | 1.44m |
Mr. Vance R. Brown Executive Vice President, General Counsel and Corporate Secretary | 0.66m |
Dr. Cheryl B. Pegus, M.D. Independent Director | 0.12m |
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific | 0.74m |
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer | 0.59m |
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director | 0.13m |
Ms. Susan E. Morano Independent Director | 0.13m |
Ms. Emily M. Woodworth Senior Vice President, Global Controller and Chief Accounting Officer | - |
Ms. Catherine R. Smith Independent Director | - |
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer | - |
Mr. Padraig A. O’Connor Executive Vice President, Global Operations | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 139,685,997 |
| BlackRock Inc | 131,822,037 |
| FMR Inc | 74,226,395 |
| Fidelity Management and Research Company | 74,226,395 |
| State Street Corp | 67,986,847 |
Director dealings
Date | Action |
|---|---|
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 28 Nov 2025 | - |
| 12 Nov 2025 | - |
| 14 Nov 2025 | - |
| 06 Nov 2025 | - |
| 03 Nov 2025 | - |
| 03 Nov 2025 | - |
| 03 Nov 2025 | - |
| 03 Nov 2025 | - |
| 03 Nov 2025 | - |
| 29 Oct 2025 | - |
| 29 Oct 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
